Logo

Biofrontera Inc.

BFRI

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-di… read more

Healthcare

Drug Manufacturers—Specialty & Generic

1 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$0.99

Price

+0.57%

$0.00

Market Cap

$10.568m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$39.181m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$16.592m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

$0.66

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

-$4.668m

$20.142m

Assets

$24.810m

Liabilities

$5.004m

Debt
Debt to Assets

24.8%

-0.3x

Debt to EBITDA
Free Cash Flow

-$9.342m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases